Dallah stock is considered one of the most attractive shares in the healthcare sector of the Saudi financial market (Tadawul). Since its listing under symbol 4004, Dallah stock has been a focal point for those interested in medical and healthcare company shares, especially with the continuous expansion of the private healthcare sector in the Kingdom. In this article, we will neutrally and analytically review everything related to Dallah stock, starting with the company's definition and activities, through its financial performance in recent years, and ending with the most important sector developments and impactful updates. We will also compare Dallah stock with its competitors in the market, providing a comprehensive overview of the factors influencing its movement and the most relevant financial indicators. This material aims to empower the reader to build a deep understanding of Dallah stock and its role in the healthcare sector, while fully adhering to the financial authority's regulations and not providing any investment recommendations or advice. We will conclude with a reminder about the importance of consulting a licensed financial advisor before making any investment decisions. Continue reading to discover all the details related to Dallah stock and the dimensions of its performance in the market.
Definition of Dallah Health Services Company and Its Core Activities
Dallah Health Services Company is one of the prominent publicly traded companies in the Saudi financial market (Tadawul) under symbol 4004. The company was established in the early 2000s and focuses on providing integrated healthcare services, including the management and operation of hospitals, clinics, and medical facilities, in addition to the distribution of pharmaceuticals and medical supplies. The company's headquarters is located in Riyadh, and it manages a network of hospitals and clinics spread across key areas within the Kingdom.
Dallah Health Services is supervised by the Capital Market Authority and health regulatory bodies, and it falls under the healthcare sector in the Saudi stock market. The company aims, through its strategies, to expand its facilities and modernize its medical services, in line with the national transformation initiatives and Saudi Vision 2030, which encourages increased private sector contributions to the healthcare system.
Dallah's revenue sources vary between inpatient services, surgical operations, emergency services, and outpatient clinics, in addition to selling pharmaceuticals and medical supplies through its outlets and pharmacies. It also has partnerships with health insurance companies and government entities to provide its services to a wide range of citizens and residents.
History of Dallah Stock Listing and Its Importance in the Saudi Market
Dallah Health Services stock was listed in the Saudi financial market (Tadawul) within the healthcare sector and is considered one of the most important stocks in this sector in terms of market value and liquidity. Since its listing, the stock has attracted interest from investors seeking growth opportunities in the healthcare services field, especially with the government's direction to improve the quality and efficiency of the private healthcare sector.
Dallah stock represents an example of the economic transformation in the Kingdom, where national policy focuses on encouraging private sector investments in health through privatization and public-private partnerships. It allows investors to participate in a sector characterized by sustainable growth due to the increasing demand for healthcare services and improved income levels of the population.
In terms of liquidity and trading, Dallah stock usually enjoys noticeable activity in daily sessions, reflecting the confidence of some investors in the future of the private healthcare sector. The company is also included in the major sector indices in Tadawul, enhancing the monitoring of institutions and investment funds regarding the stock's performance.
Analysis of Dallah Stock Performance in Recent Years
Dallah stock experienced notable price fluctuations during 2024 and 2025, with the stock price ranging between 120 and 130 Saudi Riyals, recording peak levels close to 130 Riyals in some sessions. This performance reflects the stock's response to several factors, including the company's quarterly results, news of expansions, and developments in the healthcare sector in the Saudi market.
One of the main catalysts for the stock's movements was the company's announcement of expansion projects for its hospitals and the development of new facilities in strategic areas. Quarterly financial results also played a significant role, as the company showed slight revenue and net profit growth, providing relative stability to the stock's movement.
On the other hand, the stock was affected by general market factors and macroeconomic conditions, such as fluctuations in oil prices and their indirect impact on government spending in the healthcare sector, in addition to increasing competition from health and medical technology companies. Dallah stock's performance remains an indicator of market confidence in the private Saudi healthcare sector, especially with the company's focus on expansion and long-term investment.
Key Financial Indicators for Dallah Stock
The key financial indicators for Dallah stock include the current stock price, market capitalization, price-to-earnings ratio (P/E), dividend yield, and revenue growth.
At the beginning of 2026, Dallah's stock price was approximately 121 Saudi Riyals, while the market capitalization ranged between 10 and 12 billion Riyals, placing the company among the major firms in the healthcare sector. The price-to-earnings ratio has risen to the mid-twenties, reflecting market expectations for future growth in the company's profits due to its ongoing expansions.
The dividend yield on the stock remained low, below 1%, due to the company's policy of reinvesting profits to develop healthcare facilities. Annual revenue growth has shown stability or slight increases, driven by increased demand for healthcare services and the company's geographical and technological expansion.
These indicators illustrate Dallah's focus on long-term growth rather than achieving high cash returns at the present time.
Dividend Policy and Its Role in Dallah's Strategy
Dallah Health Services Company follows a relatively conservative dividend distribution policy, preferring to reinvest most of its profits in developing and expanding its healthcare facilities. This has reflected on the dividend yield of the stock, which has remained below 1% annually in recent years.
This policy focuses on enhancing the company's operational capacity and improving the efficiency of the services provided, creating added value for shareholders in the long term through improved operational performance and increased growth opportunities. However, the company has made some nominal distributions during certain periods, considering the needs of investors, while emphasizing the priority of expansion and updating medical infrastructure.
The distribution policy remains subject to change based on market variables and available liquidity levels, and the company may reconsider it in the future if sufficient financial savings are achieved or growth priorities change.
Analysis of the Healthcare Sector in the Saudi Market
The healthcare sector in the Saudi market is witnessing accelerated growth driven by government initiatives that include increased healthcare spending and encouraging partnerships with the private sector. This sector includes a diverse range of companies, including hospital management and operation companies, pharmaceutical manufacturing and distribution companies, and health insurance providers.
The sector is characterized by sustainable demand due to population growth, demographic changes, and increased health awareness. Mandatory health insurance programs and comprehensive coverage also contribute to the increased demand for private healthcare services.
Among the challenges facing the sector are high operating costs, the need to attract medical talents, and intense competition among companies. Conversely, digitization and new medical technologies provide opportunities to enhance operational efficiency and improve the quality of services provided.
Dallah stock is an example of companies that have sought to benefit from this dynamic through expansion and the adoption of digital health solutions.
Dallah's Main Competitors in the Healthcare Sector
Dallah Health Services competes with several local and regional companies in the healthcare sector. Among the prominent competitors are major hospital management companies such as the German Saudi Healthcare Group and Dr. Suleiman Al Habib Group (although it is not listed in the market).
In the distribution of medical supplies and pharmaceuticals, Dallah overlaps with companies like Spimaco and Tabuk Pharmaceuticals, although Dallah's focus is more on clinical and administrative services for hospitals.
Competition is not limited to traditional companies; startups in the digital health field, such as Kayam and Avesina, are competing for the smart services and telemedicine segment. There is also indirect competition from health insurance companies, which control patient flow to private medical networks.
Dallah enjoys a relative advantage due to institutional support and its extensive network of facilities, along with its ability to expand geographically and technologically, placing it in a strong position within a rapidly evolving sector.
Recent Developments and Strategic Projects of Dallah
During 2024 and 2025, Dallah announced a series of expansion projects, including the establishment of new hospitals and the expansion of existing facilities in several key areas. These plans aim to increase capacity and the number of beds and available medical services.
The company also launched investments in health information technology, such as developing hospital management systems and telemedicine, enhancing operational efficiency and improving patient experience. Dallah has engaged in strategic partnerships with the government sector, through projects to operate government hospitals or partnerships with health insurance companies, thereby expanding its customer base.
These developments have positively reflected on revenues and contributed to enhancing the company's position as a leading provider of private healthcare services in the Kingdom. Monitoring the company's periodic announcements remains the best source for the latest updates on expansions and new projects.
The Relationship Between Dallah Health Services and Group Companies
Dallah Health Services is part of the Dallah Group, chaired by Dr. Loay Al-Hadid Al-Nashi, a prominent investor in several Saudi sectors. Among the related companies is Hail Cement Company (symbol 3001), which was founded by the same main owner, although it operates in a different industrial sector.
This corporate relationship contributes to enhancing Dallah's financial strength through the administrative and financial support provided by the group. Additionally, the investment diversity within the group's portfolio may achieve a form of balance in facing sectoral fluctuations, despite the differing nature of activities between health and industry.
It is important to note that the trading of Dallah stock is sometimes affected by the performance of sister or related companies, especially if impactful news is released about the group as a whole.
Overview of the Company's Quarterly and Annual Results
Dallah's quarterly financial results during 2025 showed relative stability in profits, with slight revenue growth compared to the previous year. This performance reflects the company's ability to maintain good operational levels amid market challenges and competition.
This improvement is attributed to several factors, including the expansion of medical facilities, increased demand for private healthcare services, and the adoption of modern technological solutions in hospital management. The company also benefited from its partnerships with health insurance companies and government entities in securing a stable flow of patients.
Despite the slight growth in profits, the company's policy of reinvesting a significant portion of revenues in expansions has led to low cash dividend distributions. The company's quarterly results remain a focal point for investors, given their direct impact on the stock's movement.
Factors Influencing Dallah Stock Movement
Dallah stock is influenced by several internal and external factors, including the company's quarterly and annual financial results, news of expansions and new projects, and changes in government policies related to the healthcare sector.
External factors include the performance of the Saudi economy, fluctuations in oil prices, and their impact on government healthcare spending, in addition to competition from local and international companies.
Internal factors include management efficiency, the ability to implement expansion plans, and the adoption of modern technologies in providing healthcare services. Agreements with health insurance companies also play a role in determining the demand for the company's services.
It is noteworthy that the stock may also be affected by news related to sister companies within the Dallah Group, especially in cases of joint partnerships or projects.
How to Follow Dallah Stock News and Reliable Information Sources
It is important for anyone interested in Dallah stock to follow news and reports from official and reliable sources. Among these sources is the official website of the Saudi financial market (Tadawul), which provides updated information about the company, trading data, and quarterly reports.
Websites like Argaam and Mubasher offer economic analyses and real-time coverage of the company's news and financial results. Saudi economic newspapers such as Al-Eqtisadiah and Al-Riyadh provide periodic coverage of developments in the healthcare sector and specifically Dallah stock.
Additionally, the company provides annual reports and detailed earnings reports on its official website, which are essential references for understanding the company's financial and operational performance. It is advisable to rely on these sources to ensure accurate and neutral data.
Investment Determinants in Saudi Healthcare Stocks
Investing in Saudi healthcare stocks is characterized by several features, including sustainable sector growth driven by increasing demand and supportive government policies. However, there are determinants that must be considered when analyzing any stock in this sector.
Among these determinants are high operating and expansion costs, the ongoing need to update medical equipment, intense competition from local and international companies, and changes in health regulations. The stock's performance is also influenced by the company's success in achieving geographical and technological expansion and attracting medical and administrative talents.
In the case of Dallah stock, the ability to implement new projects efficiently and expand the customer base through partnerships with health insurance companies and government entities is crucial. Anyone interested should monitor these aspects periodically.
Conclusion
In conclusion, Dallah stock emerges as an example of Saudi healthcare companies that combine operational growth and strategic expansion within a supportive economic and regulatory environment. The company benefits from the increasing demand for healthcare services while continuing to develop its facilities and adopt the latest technological solutions. However, conservative financial policies, such as reinvesting profits instead of distributing them, remain prominent features of its strategy, which reflects on the stock's financial indicators and the nature of its returns.
Those interested in following Dallah stock or the healthcare sector in general should always refer to official information sources such as Tadawul and reliable financial analysis websites, and not make any investment decisions without consulting a licensed financial advisor. The SIGMIX platform provides interested parties with tools and analyses that help them better understand the market, but the investment decision remains a personal responsibility that requires careful study and consultation with specialists.
Frequently Asked Questions
The symbol for Dallah Health Services stock in the Saudi financial market is 4004. It is traded on the main stock exchange (Tadawul) within the healthcare sector. You can follow the stock's data, price updates, and quarterly reports through the official Tadawul platform or the stock's page on financial websites like Argaam and Mubasher. The stock symbol reflects its unique identity in the Saudi market and helps investors continuously track its performance.
The main activities of Dallah Health Services Company include managing and operating hospitals, clinics, and healthcare facilities, in addition to providing distribution services for pharmaceuticals and medical supplies. The company also offers supporting services such as medical analyses and radiology, and participates in partnerships with health insurance companies and government entities to provide its services to a wide range of the community. The company focuses on continuous expansion and updating its facilities to meet the increasing demand for healthcare.
Dallah stock experienced price movements between 120 and 130 Saudi Riyals per share during 2024 and 2025, with peak levels recorded close to 130 Riyals. The stock was influenced by the company's quarterly results, news of expansions, and general market changes. Overall, the performance reflected relative stability and slight profit growth due to the company's expansions and increased demand for its services, while remaining under the influence of macroeconomic variables and competition in the sector.
The price-to-earnings ratio (P/E) for Dallah stock at the end of 2025 was around the mid-twenties, reflecting a valuation linked to future growth expectations in the company's profits. The dividend yield remained low, below 1% annually, due to the company's policy of reinvesting profits instead of distributing them significantly to shareholders. This indicates Dallah's focus on operational growth and long-term expansion.
Dallah competes with several prominent companies in the healthcare sector, including the German Saudi Healthcare Group, Spimaco, and Tabuk Pharmaceuticals, as well as digital health companies like Kayam and Avesina. There is also indirect competition from health insurance companies and diagnostic service providers. Dallah's distinction lies in its institutional support, extensive facility network, and ability to adopt modern medical technologies.
Dallah Health Services follows a conservative dividend distribution policy, preferring to reinvest most of its profits in expanding facilities and updating medical services. This policy has led to a low dividend yield for the stock (below 1%). This strategy aims to enhance operational growth and increase capacity, with the possibility of reviewing the policy based on market conditions and available liquidity in the future.
You can follow Dallah stock news and analyze its performance through the official website of Tadawul, which provides company data and quarterly reports. Financial analysis websites like Argaam and Mubasher offer periodic reports and news about the stock. Economic newspapers like Al-Eqtisadiah and Al-Riyadh provide analytical coverage of the market and companies. It is important to rely on official and periodic sources to ensure the accuracy of information.
Recent developments that have affected Dallah stock include the company's announcement of expansion projects and the establishment of new hospitals, investment in digital health technologies, and entering into partnerships with the government and insurance companies. Quarterly financial results and profit stability have also been significant points in evaluating the stock. These developments reflect the company's direction towards smart growth and enhancing its position in the Saudi healthcare sector.
Dallah Health Services is part of the Dallah Group, chaired by Dr. Loay Al-Hadid Al-Nashi, an investor in multiple sectors including Hail Cement (symbol 3001). Despite the differing activities between health and industry, this relationship provides financial and administrative support to Dallah, and the performance of sister companies sometimes affects market expectations for the stock. This diversity may achieve balance for the group in facing fluctuations in different sectors.
Determinants of investment in Saudi healthcare stocks include high operating costs, regulatory challenges, intense competition, and the ongoing need for expansion and updating medical equipment. Stocks are also influenced by macroeconomic performance, the actual implementation level of expansion projects, and changes in government policies. It is always advisable to study these determinants and consult specialists before making any investment decision in the sector.